The FTC's Ongoing Opposition To Reverse Payments

Law360 (May 8, 2008, 12:00 AM EDT) -- The "Drug Price Competition and Patent Term Restoration Act of 1984," more often called "Hatch-Waxman," regulates the generic drug industry in the United States. Hatch-Waxman reflects an attempt by Congress to balance incentives for innovation in the pharmaceutical industry with greater public access to the drugs produced by that industry....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!